Anti-Aging Efficacy of Fructosazine and Deoxyfructosazine: A Comprehensive In Vitro and In Vivo Analysis
Molecules · 2025
DOI: 10.3390/molecules30112263 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Ao Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, 2 …. Hauptthemen laut MEDLINE: Skin Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Open Sharing Fund for the Large-scale Instruments and Equipment of Dalian University of Technology, the Fundamental Research Funds of the Central Universities of China.
Abstract (Originalsprache)
As the proportion of the elderly population increases, there is an urgent need for anti-aging technologies. Since the skin is the most visibly aging organ in the human body, it is crucial to develop active ingredients to slow down skin aging. Currently, identified anti-aging active substances include antioxidants, retinoids, peptides, growth factors, and compounds derived from biofermentation. However, they have limitations such as poor stability, low transdermal permeability, skin irritation, high effective concentrations, slow onset of efficacy, single-action mechanisms, and high production costs. These limitations highlight the necessity of developing new anti-aging technologies that are multifunctional and cause low irritation. This study aimed to investigate the anti-aging effects and mechanisms of fructosazine (FZ) and deoxyfructosazine (DOF) on the skin as well as their potential applications in skincare. The methods included ELISA tests to assess the viability of human dermal fibroblast (NHDF) cells and related factors, and monitoring in Sprague-Dawley (SD) rats. The results showed that FZ promoted cell viability. Both FZ and DOF enhanced the secretion of type I collagen (Col I) and hyaluronic acid (HA), inhibited matrix metalloproteinase-1 (MMP-1), boosted catalase (CAT), and reduced malondialdehyde (MDA), reactive oxygen species (ROS), and β-galactosidase. They also nourished the epidermis and increased fiber content. In conclusion, FZ and DOF can stimulate the production of anti-aging substances, exhibit antioxidant activity, and have potential in skincare.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Fine Chemicals, Department of Pharmaceutical Engineering, School of Chemical Engineering, Dalian University of Technology, 2 Linggong Road, Dalian 116024, China.
- Ningbo Institute of Dalian University of Technology, No. 26 Yucai Road, Jiangbei District, Ningbo 315016, China.
- Liaoning Binhai Laboratory, Dalian 116023, China.
ORCID-Profile: Wenhui Li, Shixuan Lv, Yueqing Li
Förderung
- National Natural Science Foundation of China
- Open Sharing Fund for the Large-scale Instruments and Equipment of Dalian University of Technology
- the Fundamental Research Funds of the Central Universities of China
- Liaoning Binhai Laboratory
Zitieren
APA
Yang, A., Ma, C., Song, Q., Li, W., Lv, S., Guo, X., Wang, S., Gao, Z., Wang, S., Meng, Q., & Li, Y. (2025). Anti-Aging Efficacy of Fructosazine and Deoxyfructosazine: A Comprehensive In Vitro and In Vivo Analysis. Molecules. https://doi.org/10.3390/molecules30112263
Vancouver
Yang A, Ma C, Song Q, Li W, Lv S, Guo X, et al. Anti-Aging Efficacy of Fructosazine and Deoxyfructosazine: A Comprehensive In Vitro and In Vivo Analysis. Molecules. 2025. doi:10.3390/molecules30112263
BibTeX
@article{Yang2025,
author = {Yang, Ao and Ma, Chunyan and Song, Qiling and Li, Wenhui and Lv, Shixuan and Guo, Xiuhan and Wang, Shisheng and Gao, Zhigang and Wang, Shuai and Meng, Qingwei and Li, Yueqing},
title = {Anti-Aging Efficacy of Fructosazine and Deoxyfructosazine: A Comprehensive In Vitro and In Vivo Analysis},
journal = {Molecules},
year = {2025},
doi = {10.3390/molecules30112263}
}
EUVIMED